Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE - Anti-dilutive (Details)

v3.21.1
EARNINGS PER SHARE - Anti-dilutive (Details) - shares
3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common stock equivalents were excluded from the computation of diluted net loss per share 2,311 1,581
Employee stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common stock equivalents were excluded from the computation of diluted net loss per share 874 963
Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common stock equivalents were excluded from the computation of diluted net loss per share 1,437 618